From molecule to absorption: a multiscale framework for subcutaneous biologic delivery
Advanced Drug Delivery Reviews · 2026-06 · 233 · 115857
DOI: 10.1016/j.addr.2026.115857 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-06. Verfasst von Mario de Lucio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: mario.delucio@lilly.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Subcutaneous (SC) injection has become the preferred route for self-administered monoclonal antibodies (mAbs), yet achieving consistent bioavailability remains challenging because molecular-scale interactions (protein self-association) propagate through device mechanics (cavitation, sloshing) into tissue response (depot geometry, lymphatic uptake) as a coupled system where optimizing any single component in isolation yields diminishing returns. This review introduces the Drug-Device-Container-Tissue (DDCT) framework-a unified, multiscale approach that traces the monoclonal antibody (mAb) journey from storage through injection to lymphatic absorption. We synthesize findings from molecular dynamics simulations, rheological measurements, high-speed imaging, and poromechanical modeling to establish four key principles. First, concentration-dependent viscosity and diffusion arise from antibody self-association, directly impacting injectability and tissue transport. Second, device actuation induces sloshing, cavitation, and hydrodynamic shear, which can compromise protein stability; design strategies to mitigate these phenomena are now well-characterized. Third, device actuation parameters such as spring force and injection time critically influence delivery reliability and the risk of intramuscular injection. Fourth, tissue heterogeneity-including adipocyte geometry, collagen septa, and lymphatic distribution-governs depot formation and absorption kinetics in ways that patient-specific factors such as body mass index significantly modulate. By mapping these coupled phenomena across scales, the DDCT framework identifies cross-interface interactions as the critical bottleneck for optimizing SC delivery, providing a foundation for the rational design of next-generation autoinjectors, high-concentration formulations, and predictive computational tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: mario.delucio@lilly.com.
- Eli Lilly and Company, Indianapolis, IN, USA.
- School of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, USA.
- Eli Lilly and Company, Indianapolis, IN, USA; School of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, USA. Electronic address: pavlos.vlachos@lilly.com.
Zitieren
APA
de Lucio, M., Sree, V., Shi, G., Collins, D., Veilleux, J. C., Gomez, H., & Vlachos, P. P. (2026). From molecule to absorption: a multiscale framework for subcutaneous biologic delivery. Advanced Drug Delivery Reviews, 233, 115857. https://doi.org/10.1016/j.addr.2026.115857
Vancouver
de Lucio M, Sree V, Shi G, Collins D, Veilleux JC, Gomez H, et al. From molecule to absorption: a multiscale framework for subcutaneous biologic delivery. Advanced Drug Delivery Reviews. 2026;233:115857. doi:10.1016/j.addr.2026.115857
BibTeX
@article{deLucio2026,
author = {de Lucio, Mario and Sree, Vivek and Shi, Galen and Collins, David and Veilleux, Jean-Christophe and Gomez, Hector and Vlachos, Pavlos P},
title = {From molecule to absorption: a multiscale framework for subcutaneous biologic delivery},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {233},
pages = {115857},
doi = {10.1016/j.addr.2026.115857}
}
EUVIMED